No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
APLT250117C1000
- 0.13
- -0.07-35.00%
15min DelayClose Dec 20 16:00 ET
0.17High0.10Low
0.12Open0.20Pre Close1.05K Volume1.98K Open Interest1.00Strike Price14.12KTurnover186.94%IV28.41%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.4974Delta0.9194Gamma6.77Leverage Ratio-0.0035Theta0.0002Rho3.37Eff Leverage0.0009Vega
Intraday
- 5D
- Daily
News
William Blair Downgrades Applied Therapeutics to Market Perform
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5
Applied Therapeutics Is Maintained at Sector Perform by RBC Capital
Applied Therapeutics Analyst Ratings
Applied Therapeutics CEO Shendelman Steps Down